Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indra Neil Guha

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Nature Medicine|October 31, 2023
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J Kendall, Maria Jimenez-Ramos, Frances Turner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2021
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the PopulationIsabel Graupera, Maja Thiele, Miquel Serra-Burriel, et al.
Hepatology (Baltimore, Md.)|July 18, 2018
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisSamuel J Daniels, Diana J Leeming, Mohammed Eslam, et al.
Journal of Hepatology|August 31, 2019
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaMiquel Serra-Burriel, Isabel Graupera, Pere Torán, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Implementation of a liver health check in people with type 2 diabetesKushala W M Abeysekera, Luca Valenti, Zobair Younossi, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Nature Medicine|October 31, 2023
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J Kendall, Maria Jimenez-Ramos, Frances Turner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2021
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the PopulationIsabel Graupera, Maja Thiele, Miquel Serra-Burriel, et al.
Hepatology (Baltimore, Md.)|July 18, 2018
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisSamuel J Daniels, Diana J Leeming, Mohammed Eslam, et al.
Journal of Hepatology|August 31, 2019
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaMiquel Serra-Burriel, Isabel Graupera, Pere Torán, et al.
Gastroenterology|June 21, 2020
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1Hamish Innes, Stephan Buch, Sharon Hutchinson, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Implementation of a liver health check in people with type 2 diabetesKushala W M Abeysekera, Luca Valenti, Zobair Younossi, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Pageof 6